Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FENC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Marco Maria Brughera Director | FENC Fennec Pharmaceuticals Inc. | Sale | 15,545 | $10.29 | $160.0K Sale | Form 4 ↗ |
| Sep 1, 2026 | Rosty Raykov | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $12.11 | $121.1K Sale | Form 4 ↗ |
| Aug 31, 2026 | Pierre Sargis Sayad Chief Medical Officer | FENC Fennec Pharmaceuticals Inc. | Sale | 12,000 | $12.18 | $146.2K Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Andrade CHIEF FINANCIAL OFFICER | FENC Fennec Pharmaceuticals Inc. | Sale | 75,000 | $11.78 | $883.5K Sale | Form 4 ↗ |
| Aug 3, 2026 | Rosty Raykov | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $9.58 | $95.8K Sale | Form 4 ↗ |
| Jul 1, 2026 | Rosty Raykov | FENC Fennec Pharmaceuticals Inc. | Sale | 9,599 | $10.41 | $99.9K Sale | Form 4 ↗ |
| Jun 1, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 9,747 | $9.62 | $93.8K Sale | Form 4 ↗ |
| May 11, 2026 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 8,346 | $7.04 | $58.8K Sale | Form 4 ↗ |
| May 1, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,781 | $6.47 | $69.8K Sale | Form 4 ↗ |
| Apr 1, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,946 | $6.31 | $69.1K Sale | Form 4 ↗ |
| Mar 2, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,079 | $8.36 | $84.3K Sale | Form 4 ↗ |
| Feb 2, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,349 | $7.76 | $80.3K Sale | Form 4 ↗ |
| Jan 2, 2026 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,312 | $7.60 | $78.4K Sale | Form 4 ↗ |
| Dec 24, 2025 | Southpoint Capital Advisors LP 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 1.00M | $7.50 | $7.5M Sale | Form 4 ↗ |
| Dec 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $7.54 | $75.4K Sale | Form 4 ↗ |
| Nov 18, 2025 | Southpoint Capital Advisors LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 19,341 | $8.79 | $170.0K Sale | Form 4 ↗ |
| Nov 17, 2025 | Southpoint GP, LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 85,918 | $8.79 | $755.2K Sale | Form 4 ↗ |
| Nov 14, 2025 | Southpoint GP, LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 160,100 | $8.00 | $1.3M Sale | Form 4 ↗ |
| Nov 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $8.10 | $81.0K Sale | Form 4 ↗ |
| Oct 10, 2025 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,775 | $9.24 | $16.4K Sale | Form 4 ↗ |
| Oct 9, 2025 | Southpoint Capital Advisors LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 20,609 | $9.35 | $192.7K Sale | Form 4 ↗ |
| Oct 8, 2025 | Southpoint Capital Advisors LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 19,605 | $9.47 | $185.7K Sale | Form 4 ↗ |
| Oct 7, 2025 | Southpoint Capital Advisors LLC 10% owner | FENC Fennec Pharmaceuticals Inc. | Sale | 26,900 | $9.59 | $258.0K Sale | Form 4 ↗ |
| Oct 6, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $9.78 | $97.8K Sale | Form 4 ↗ |
| Sep 4, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $8.92 | $89.2K Sale | Form 4 ↗ |
| Aug 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $8.09 | $80.9K Sale | Form 4 ↗ |
| Jul 7, 2025 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,119 | $8.71 | $9,746 Sale | Form 4 ↗ |
| Jul 3, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $8.61 | $86.1K Sale | Form 4 ↗ |
| Jun 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $7.78 | $77.8K Sale | Form 4 ↗ |
| May 19, 2025 | Jeffrey S. Hackman Chief Executive Officer, Director | FENC Fennec Pharmaceuticals Inc. | Buy | 13,965 | $6.99 | $97.6K Buy | Form 4 ↗ |
| May 16, 2025 | Jeffrey S. Hackman Chief Executive Officer, Director | FENC Fennec Pharmaceuticals Inc. | Buy | 1,035 | $6.75 | $6,986 Buy | Form 4 ↗ |
| May 16, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 16,667 | $6.78 | $113.0K Sale | Form 4 ↗ |
| May 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $6.31 | $63.1K Sale | Form 4 ↗ |
| Apr 11, 2025 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,409 | $4.95 | $6,975 Sale | Form 4 ↗ |
| Apr 4, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $5.25 | $52.5K Sale | Form 4 ↗ |
| Mar 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $6.79 | $67.9K Sale | Form 4 ↗ |
| Feb 14, 2025 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,186 | $6.82 | $8,089 Sale | Form 4 ↗ |
| Feb 5, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 10,000 | $6.66 | $66.6K Sale | Form 4 ↗ |
| Jan 6, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 7,569 | $6.08 | $46.0K Sale | Form 4 ↗ |
| Jan 6, 2025 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 2,431 | $6.08 | $14.8K Sale | Form 4 ↗ |
| Dec 5, 2024 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 796 | $6.04 | $4,808 Sale | Form 4 ↗ |
| Dec 3, 2024 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,635 | $6.13 | $10.0K Sale | Form 4 ↗ |
| Dec 2, 2024 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 6,409 | $6.14 | $39.4K Sale | Form 4 ↗ |
| Nov 4, 2024 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 2,431 | $4.31 | $10.5K Sale | Form 4 ↗ |
| Oct 8, 2024 | Chris A. Rallis Director | FENC Fennec Pharmaceuticals Inc. | Sale | 1,406 | $4.53 | $6,369 Sale | Form 4 ↗ |
| Oct 1, 2024 | Rosty Raykov Director | FENC Fennec Pharmaceuticals Inc. | Sale | 2,431 | $4.94 | $12.0K Sale | Form 4 ↗ |
46 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:05 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances